Chromenone-based GSK-3β inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles

Chromenone-based GSK-3β inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles

Glycogen synthase kinase-3 beta (GSK-3β) regulates glycogen metabolism and many different cellulars, including apoptosis, signaling, and neural. It is a crucial therapeutic receptor in heart disease, type 2 diabetes, and Alzheimer's. In this study, using computational methods, flavonoid compoun...

Full description

Bibliographic Details
Main Authors:	Min Zhang, San Zhou, Noor H. Obaid, Usama S. Altimari, Mohanad Adel Mohammed, Ahmed Kareem Obaid Aldulaim, Emad Salaam Abood, Hossam Kotb, Ayesheh Enayati, Vahid Khori, Hassan Mirzaei, Aref Salehi, Alireza Soltani, Mohd Sani Sarjadi, Md. Lutfor Rahman
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Arabian Journal of Chemistry
Subjects:	GSK-3β Chromenone Virtual screening Molecular dynamics simulation ADMET
Online Access:	http://www.sciencedirect.com/science/article/pii/S1878535222006049

Similar Items

Chromenone-based GSK-3ß inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles
by: Min Zhang, et al.
Published: (2022)

Synthesis of 2H-Chromenones from Salicylaldehydes and Arylacetonitriles
by: Chengcai Li, et al.
Published: (2017-07-01)

Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study
by: Ali Asadipour, et al.
Published: (2024-04-01)

Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
by: Hajar Karimi Askarani, et al.
Published: (2020-10-01)

Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile
by: Yuan Xu, et al.
Published: (2022-07-01)

ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database
by: Jie Dong, et al.
Published: (2018-06-01)

Brønsted Acidic Phosphonium Based Ionic Liquid Functionalized SBA-15 [HO3S-PhospIL@SBA-15]: Green, Recyclable, and Efficient Catalyst for the Synthesis of Pyrano[3,2-c]Chromenone Derivatives
by: Mina Saeedi, et al.
Published: (2015-12-01)

5-Hydroxy-2-phenyl-7-(prop-2-yn-1-yloxy)-4H-chromen-4-one
by: Fan Yang, et al.
Published: (2017-04-01)

FP-ADMET: a compendium of fingerprint-based ADMET prediction models
by: Vishwesh Venkatraman
Published: (2021-09-01)

3-(3-Bromophenyl)-7-acetoxycoumarin
by: Petri A. Turhanen, et al.
Published: (2022-12-01)

Lipophilicity and ADMET Analysis of Quinoline-1,4-quinone Hybrids
by: Monika Kadela-Tomanek, et al.
Published: (2022-12-01)

GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
by: Octavio Silva-García, et al.
Published: (2020-12-01)

ADMET and Druglikeness Calculations of Sarin, Soman, and Their Hypothetical Derivatives
by: Kafa Khalaf Hammud
Published: (2022-12-01)

Chromatographic technique to support ADMET&DMPK in early drug discovery
by: Klara Livia Valko
Published: (2018-06-01)

Synthesis and antibacterial activity of pyrano[3,2-g]chromene-4,6-dione derivatives and their molecular docking and DFT calculation studies
by: Janani Mullaivendhan, et al.
Published: (2023-12-01)

Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
by: Kwanghee Ahn, et al.
Published: (2019-05-01)

Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
by: Selvi Kunnimalaiyaan, et al.
Published: (2018-05-01)

Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone
by: Mohammed Aarjane, et al.
Published: (2020-07-01)

Synthesis of Natural Homoisoflavonoids Having Either 5,7-Dihydroxy-6-methoxy or 7-Hydroxy-5,6-dimethoxy Groups
by: Hyungjun Lee, et al.
Published: (2016-08-01)

Potentilla reptans L. postconditioning protects reperfusion injury via the RISK/SAFE pathways in an isolated rat heart
by: Ayesheh Enayati, et al.
Published: (2021-11-01)

Special issue devoted to the 6th IAPC Meeting: joint events comprising 6th World conference on physico-chemical methods in drug discovery and development and 3rd World conference on ADMET and DMPK
by: Kin Tam, et al.
Published: (2018-03-01)

ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes
by: Przemysław Czeleń, et al.
Published: (2023-11-01)

Physicochemical, spectral, molecular docking and ADMET studies of Bisphenol analogues; A computational approach
by: Monir Uzzaman, et al.
Published: (2021-01-01)

Four New Chromones from the Endophytic Fungus <i>Phomopsis asparagi</i> DHS-48 Isolated from the Chinese Mangrove Plant <i>Rhizophora mangle</i>
by: Chengwen Wei, et al.
Published: (2021-06-01)

Crystal structure of 3-[4-(benzyloxy)phenyl]-2,3-dihydro-1H-benzo[f]chromen-1-one
by: R. Vasanthi, et al.
Published: (2014-10-01)

Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
by: Joyce E. Gutiérrez, et al.
Published: (2023-12-01)

Novel 1,3,4-Thiadiazole Derivatives as Antibiofilm, Antimicrobial, Efflux Pump Inhibiting Agents and Their ADMET Characterizations
by: Ergin Murat Altuner, et al.
Published: (2023-06-01)

New coumarin derivative with potential antioxidant activity: Synthesis, DNA binding and in silico studies (Docking, MD, ADMET)
by: Serda Kecel-Gunduz, et al.
Published: (2023-02-01)

Synthesis, biological evaluation, molecular docking and in silico ADMET screening studies of novel isoxazoline derivatives from acridone
by: Mohammed Aarjane, et al.
Published: (2021-04-01)

Antibacterial Potential of Ximenia americana L. Olacaceae: Molecular Docking, Molecular Dynamics, and ADMET Prediction
by: Mubarak Muhammad Dahiru, et al.
Published: (2024-01-01)

Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach
by: Ranjan K. Mohapatra, et al.
Published: (2023-09-01)

Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway
by: Hsuan-Yeh Pan, et al.
Published: (2022-02-01)

ADMET profiling and molecular docking of pyrazole and pyrazolines derivatives as antimicrobial agents
by: Fatima EN-NAHLI, et al.
Published: (2023-11-01)

ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01)

Synthesis, Molecular Docking, Druglikeness Analysis, and ADMET Prediction of the Chlorinated Ethanoanthracene Derivatives as Possible Antidepressant Agents
by: Mujeeb A. Sultan, et al.
Published: (2020-10-01)

Thiazolopyrimidine as a Promising Anticancer Pharmacophore: In Silico Drug Design, Molecular Docking and ADMET Prediction Studies
by: Omar A. El-Khouly, et al.
Published: (2022-11-01)

In Silico Molecular Docking and ADMET Analysis for Drug Development of Phytoestrogens Compound with Its Evaluation of Neurodegenerative Diseases
by: Faisal Akhmal Muslikh, et al.
Published: (2022-11-01)

ADMET Polymerization of Dimeric Cinchona Squaramides for the Preparation of a Highly Enantioselective Polymeric Organocatalyst
by: Mohammad Shahid Ullah, et al.
Published: (2020-05-01)

Quantitative Structure-Activity relationship, Molecular Docking and ADMET Screening of Tetrahydroquinoline Derivatives as Anti-Small Cell Lung Cancer Agents
by: Ehimen Annastasia Erazua, et al.
Published: (2023-01-01)

GSK3: A Kinase Balancing Promotion and Resolution of Inflammation
by: Leonie Hoffmeister, et al.
Published: (2020-03-01)